Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.

Quraishi MNN, Yalchin M, Blackwell C, Segal J, Sharma N, Hawkey P, McCune V, Hart AL, Gaya D, Ives NJ, Magill L, Loi S, Hewitt C, Gerasimidis K, Loman NJ, Hansen R, McMullan C, Mathers J, Quince C, Crees N, Iqbal T.

BMJ Open. 2019 Nov 11;9(11):e030659. doi: 10.1136/bmjopen-2019-030659.

2.

Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.

Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ; PREDNOS Collaborative Group.

BMJ. 2019 May 23;365:l1800. doi: 10.1136/bmj.l1800.

3.

Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine.

Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives NJ, Clarke CE, Sinclair AJ.

BMJ Open. 2019 Jul 16;9(7):e027953. doi: 10.1136/bmjopen-2018-027953.

4.

Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.

Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.

Health Technol Assess. 2019 May;23(26):1-108. doi: 10.3310/hta23260.

5.

Treatment of fatigue with physical activity and behavioural change support in vasculitis: study protocol for an open-label randomised controlled feasibility study.

Harper L, Morgan MD, Chanouzas D, Caulfield HK, Coughlan L, Dean C, Fletcher K, Cramp F, Greenfield S, Hewitt CA, Ives NJ, Jowett S, Daley A.

BMJ Open. 2018 Oct 30;8(10):e023769. doi: 10.1136/bmjopen-2018-023769.

6.

Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol.

Kyte D, Bishop J, Brettell E, Calvert M, Cockwell P, Dutton M, Eddington H, Hadley G, Ives NJ, Jackson LJ, Stringer S, Valente M.

BMJ Open. 2018 Oct 28;8(10):e026080. doi: 10.1136/bmjopen-2018-026080.

7.

Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children.

Lambe T, Frew E, Ives NJ, Woolley RL, Cummins C, Brettell EA, Barsoum EN, Webb NJA; PREDNOS Trial Team.

Pharmacoeconomics. 2018 Apr;36(4):451-465. doi: 10.1007/s40273-017-0600-7.

PMID:
29264866
8.

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol.

Ottridge R, Mollan SP, Botfield H, Frew E, Ives NJ, Matthews T, Mitchell J, Rick C, Singhal R, Woolley R, Sinclair AJ.

BMJ Open. 2017 Sep 27;7(9):e017426. doi: 10.1136/bmjopen-2017-017426.

9.

Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis.

Ives NJ, Suciu S, Eggermont AMM, Kirkwood J, Lorigan P, Markovic SN, Garbe C, Wheatley K; International Melanoma Meta-Analysis Collaborative Group (IMMCG).

Eur J Cancer. 2017 Sep;82:171-183. doi: 10.1016/j.ejca.2017.06.006. Epub 2017 Jul 7. Review.

PMID:
28692949
10.

Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.

Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ; PREDNOS 2 study group.

Trials. 2014 Apr 27;15:147. doi: 10.1186/1745-6215-15-147.

11.

Is non-invasive testing for sexually transmitted infections an efficient and acceptable alternative for patients? A randomised controlled trial.

Brown L, Patel S, Ives NJ, McDermott C, Ross JD.

Sex Transm Infect. 2010 Dec;86(7):525-31. doi: 10.1136/sti.2009.039479. Epub 2010 Aug 26.

PMID:
20798395
12.

Dopamine agonist therapy in early Parkinson's disease.

Stowe RL, Ives NJ, Clarke C, van Hilten J, Ferreira J, Hawker RJ, Shah L, Wheatley K, Gray R.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006564. doi: 10.1002/14651858.CD006564.pub2. Review.

PMID:
18425954
13.
14.

Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.

van Hilten JJ, Ramaker CC, Stowe R, Ives NJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003634. Review.

PMID:
17943795
15.

Bromocriptine versus levodopa in early Parkinson's disease.

van Hilten JJ, Ramaker CC, Stowe R, Ives NJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD002258. Review.

PMID:
17943771
16.

Does adjuvant vaccine therapy really have activity in malignant melanoma?

Wheatley K, Ives NJ, Lorigan P.

J Clin Oncol. 2007 Oct 10;25(29):4693; author reply 4693-5. No abstract available.

PMID:
17925569
17.

Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients.

Ives NJ, Stowe RL, Marro J, Counsell C, Macleod A, Clarke CE, Gray R, Wheatley K.

BMJ. 2004 Sep 11;329(7466):593. Epub 2004 Aug 13.

18.

High-dose chemotherapy for breast cancer.

Wheatley K, Gray RG, Ives NJ.

N Engl J Med. 2003 Oct 9;349(15):1476-9; author reply 1476-9. No abstract available.

PMID:
14534343
19.

Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials.

Adu D, Cockwell P, Ives NJ, Shaw J, Wheatley K.

BMJ. 2003 Apr 12;326(7393):789.

20.

Surgery for Parkinson's disease: lack of reliable clinical trial evidence.

Stowe RL, Wheatley K, Clarke CE, Ives NJ, Hills RK, Williams AC, Daniels JP, Gray R.

J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):519-21. Review.

21.

Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials.

Ives NJ, Wheatley K, Stowe RL, Krijnen P, Plouin PF, van Jaarsveld BC, Gray R.

Nephrol Dial Transplant. 2003 Feb;18(2):298-304.

PMID:
12543884
22.

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL.

AIDS. 2002 Jan 4;16(1):75-83.

PMID:
11741165
23.

Does an HIV clinical trial information booklet improve patient knowledge and understanding of HIV clinical trials?

Ives NJ, Troop M, Waters A, Davies S, Higgs C, Easterbrook PJ.

HIV Med. 2001 Oct;2(4):241-9.

24.

How generalizable are the results of large randomized controlled trials of antiretroviral therapy?

Moore DA, Goodall RL, Ives NJ, Hooker M, Gazzard BG, Easterbrook PJ.

HIV Med. 2000 Jul;1(3):149-54.

25.

Incidence and risk factors for the development of indinavir-associated renal complications.

Herman JS, Ives NJ, Nelson M, Gazzard BG, Easterbrook PJ.

J Antimicrob Chemother. 2001 Sep;48(3):355-60.

PMID:
11532999
26.

Supplemental Content

Support Center